Joseph Vazzano
2022 - Abeona Therapeutics
In 2022, Joseph Vazzano earned a total compensation of $918.6K as Chief Financial Officer at Abeona Therapeutics.
Compensation breakdown
| Bonus | $60,000 |
|---|---|
| Non-Equity Incentive Plan | $197,333 |
| Salary | $307,769 |
| Stock Awards | $341,270 |
| Other | $12,200 |
| Total | $918,572 |
Vazzano received $341.3K in stock awards, accounting for 37% of the total pay in 2022.
Vazzano also received $60K in bonus, $197.3K in non-equity incentive plan, $307.8K in salary and $12.2K in other compensation.
Rankings
In 2022, Joseph Vazzano's compensation ranked 3,221st out of 5,756 executives tracked by ExecPay. In other words, Vazzano earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,221 out of 5,756 | 44th |
Division Manufacturing | 1,811 out of 3,133 | 42nd |
Major group Chemicals And Allied Products | 861 out of 1,419 | 39th |
Industry group Drugs | 805 out of 1,320 | 39th |
Industry Pharmaceutical Preparations | 587 out of 966 | 39th |
Source: SEC filing on April 13, 2023.
Vazzano's colleagues
We found three more compensation records of executives who worked with Joseph Vazzano at Abeona Therapeutics in 2022.
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019